Tag: medicine manufacturing
Bora renews manufacturing partnership with GSK in new $250M deal
Global pharmaceutical manufacturing companies Bora Pharmaceuticals and GSK have agreed to renew their manufacturing partnership for another five years in a new $250 million (AUD 353.8 million) contract.
Australia’s nuclear medicine manufacturing capability gets gov’t boost
The Australian government is investing in the Australian Nuclear Science and Technology Organisation (ANSTO) to boost Australia’s sovereign capability to manufacture nuclear medicine that will help in the treatment of diseases like cancer.
Pharmaxis’ locally manufactured cystic fibrosis drug lands in the US
Australian pharmaceutical research company Pharmaxis Ltd (ASX:PXS) exported the first shipment of its locally developed and manufactured cystic fibrosis (CF) drug Bronchitol™ (mannitol) to...
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
